
/
RSS Feed
SAN DIEGO–(BUSINESS WIRE)–Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect? (antibody conjugation) and HydraSpace? (highly polar spacer). Familiarity with these Antibody-Drug Conjugate (ADC) technologies adds to Abzena?s leadership in process development and GMP manufacturing of ADC linkers and payloads. Abzena can now rapidly ramp up ADC projects using Syn